• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人食管腺癌中 MicroRNAs 的表达特征和作用。

Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas.

机构信息

Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Department of Breast Oncology, National Cancer Center/Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

J Cell Mol Med. 2018 Jan;22(1):123-130. doi: 10.1111/jcmm.13300. Epub 2017 Aug 10.

DOI:10.1111/jcmm.13300
PMID:28799211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5742716/
Abstract

The most common forms of oesophageal cancers are adenocarcinomas and squamous cell carcinoma (SCC). Although the incidence of SCC in the United States tends to be declining, the adenocarcinoma incidence caused by Barrett's oesophagus has been increasing. Oesophageal cancer is regarded as one of the most fatal malignancies with a short prognosis. Systemic manifestations of patients with PCNSL keep backward in spite of recent development of chemoradiotherapy. MicroRNAs are small non-coding RNAs that can post-transcriptionally down-regulate the expression of genes by targeting mRNAs, causing their translational repression as well as degradation. MicroRNAs exert critical functions in many malignancy-related biological processes, including cell apoptosis, metabolism, proliferation and differentiation. Many deregulated miRNAs have been identified in oesophageal adenocarcinomas, but their biological importance has not yet been fully elucidated. In this study, we review present evidence regarding the potential applications of oesophageal adenocarcinomas associated microRNAs for prognosis and diagnosis of this lethal disease.

摘要

最常见的食管癌类型为腺癌和鳞状细胞癌(SCC)。虽然 SCC 在 美国的发病率呈下降趋势,但 Barrett 食管引起的腺癌发病率一直在上升。食管癌被认为是预后最差的最致命恶性肿瘤之一。尽管最近开展了放化疗,但原发性中枢神经系统淋巴瘤患者的全身表现仍在不断恶化。微小 RNA 是一种小的非编码 RNA,可以通过靶向 mRNAs 来转录后下调基因的表达,从而导致其翻译抑制和降解。微小 RNA 在许多与恶性肿瘤相关的生物学过程中发挥着关键作用,包括细胞凋亡、代谢、增殖和分化。在食管腺癌中已经发现了许多失调的微小 RNA,但它们的生物学重要性尚未完全阐明。在本研究中,我们回顾了与食管腺癌相关微小 RNA 用于该致命疾病的预后和诊断的潜在应用的现有证据。

相似文献

1
Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas.人食管腺癌中 MicroRNAs 的表达特征和作用。
J Cell Mol Med. 2018 Jan;22(1):123-130. doi: 10.1111/jcmm.13300. Epub 2017 Aug 10.
2
A review of the current understanding and clinical utility of miRNAs in esophageal cancer.食管癌中 miRNA 的研究现状及临床应用综述。
Semin Cancer Biol. 2013 Dec;23(6 Pt B):512-21. doi: 10.1016/j.semcancer.2013.08.005. Epub 2013 Sep 3.
3
Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.微小RNA表达谱的动态变化反映了巴雷特食管向食管腺癌的进展。
Carcinogenesis. 2015 May;36(5):521-7. doi: 10.1093/carcin/bgv023. Epub 2015 Mar 16.
4
MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.巴雷特食管消融术后新生食管鳞状黏膜中的 microRNA 谱。
World J Gastroenterol. 2017 Aug 14;23(30):5508-5518. doi: 10.3748/wjg.v23.i30.5508.
5
MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.巴雷特食管和食管腺癌的 microRNA 图谱分析。
Br J Surg. 2010 Jun;97(6):853-61. doi: 10.1002/bjs.7000.
6
MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus.巴雷特食管恶性进展过程中的微小RNA表达特征
J Cell Biochem. 2016 Jun;117(6):1288-95. doi: 10.1002/jcb.25497. Epub 2016 Feb 16.
7
Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas.热休克蛋白27(Hsp27)在正常食管、巴雷特化生及食管腺癌中的差异表达。
Br J Cancer. 1999 Feb;79(3-4):595-603. doi: 10.1038/sj.bjc.6690094.
8
Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.炎症和 microRNA 基因表达作为 Barrett's 相关食管腺癌的预后分类器。
Clin Cancer Res. 2010 Dec 1;16(23):5824-34. doi: 10.1158/1078-0432.CCR-10-1110. Epub 2010 Oct 14.
9
Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma.在从巴雷特化生进展为食管腺癌的过程中,去分化先于侵袭发生。
Clin Cancer Res. 2005 Apr 1;11(7):2478-85. doi: 10.1158/1078-0432.CCR-04-1280.
10
HER2 expression in oesophageal carcinoma and Barrett's oesophagus associated adenocarcinoma: An Australian study.人表皮生长因子受体2(HER2)在食管癌及巴雷特食管相关腺癌中的表达:一项澳大利亚的研究。
Eur J Surg Oncol. 2016 Jan;42(1):140-8. doi: 10.1016/j.ejso.2015.08.159. Epub 2015 Sep 10.

引用本文的文献

1
ENPP4 overexpression is associated with no recovery from Barrett's esophagus.ENPP4过表达与巴雷特食管无法恢复相关。
Int J Clin Exp Pathol. 2020 Dec 1;13(12):2927-2936. eCollection 2020.
2
A narrative review of Barrett's esophagus in 2020, molecular and clinical update.2020年巴雷特食管的叙述性综述:分子与临床进展
Ann Transl Med. 2020 Sep;8(17):1107. doi: 10.21037/atm-20-4406.
3
MicroRNA‑216a‑5p suppresses esophageal squamous cell carcinoma progression by targeting KIAA0101.微小 RNA-216a-5p 通过靶向 KIAA0101 抑制食管鳞状细胞癌进展。
Oncol Rep. 2020 Nov;44(5):1971-1984. doi: 10.3892/or.2020.7751. Epub 2020 Sep 4.
4
Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma.循环外泌体微小RNA作为巴雷特食管和食管腺癌的潜在生物标志物
World J Gastroenterol. 2020 Jun 14;26(22):2889-2901. doi: 10.3748/wjg.v26.i22.2889.

本文引用的文献

1
Cysteine-linked dimerization of BST-2 confers anoikis resistance to breast cancer cells by negating proapoptotic activities to promote tumor cell survival and growth.BST-2的半胱氨酸连接二聚化通过消除促凋亡活性赋予乳腺癌细胞抗失巢凋亡能力,从而促进肿瘤细胞存活和生长。
Cell Death Dis. 2017 Mar 16;8(3):e2687. doi: 10.1038/cddis.2017.68.
2
The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.微小RNA在乳腺癌中的预后及治疗应用:组织和循环微小RNA
J Cell Physiol. 2018 Feb;233(2):774-786. doi: 10.1002/jcp.25813. Epub 2017 Mar 24.
3
Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma.长链非编码RNA小核仁RNA宿主基因12(SNHG12)通过靶向肝细胞癌中的miR-199a/b-5p促进肿瘤发生和转移。
J Exp Clin Cancer Res. 2017 Jan 10;36(1):11. doi: 10.1186/s13046-016-0486-9.
4
The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.致癌性微小RNA在乳腺癌中的作用及其治疗意义。
Eur J Cancer. 2017 Feb;72:1-11. doi: 10.1016/j.ejca.2016.11.004. Epub 2016 Dec 18.
5
Circulating miRNA profile in esophageal adenocarcinoma.食管腺癌中的循环微小RNA谱
Am J Cancer Res. 2016 Nov 1;6(11):2713-2721. eCollection 2016.
6
Circulating MicroRNAs in Cancer.癌症中的循环微小RNA
Methods Mol Biol. 2017;1509:123-139. doi: 10.1007/978-1-4939-6524-3_12.
7
miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression.miR-221 通过直接靶向 DKK2 表达介导食管腺癌的化疗耐药性。
Ann Surg. 2016 Nov;264(5):804-814. doi: 10.1097/SLA.0000000000001928.
8
Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study.非小细胞肺癌患者中三种 microRNA(miR-26a、miR-29b 和 miR-519d)与基质金属蛋白酶-2(MMP-2)表达水平的相关性分析:一项初步研究。
Med Oncol. 2016 Aug;33(8):96. doi: 10.1007/s12032-016-0815-z. Epub 2016 Jul 22.
9
Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.miR-145 和 miR-9 表达水平的分子鉴定作为早期宫颈癌检测的预后生物标志物。
QJM. 2017 Jan;110(1):11-15. doi: 10.1093/qjmed/hcw101. Epub 2016 Jun 26.
10
MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.miR-26a 通过靶向 Jagged1 抑制骨肉瘤干细胞样表型和肿瘤生长。
Oncogene. 2017 Jan 12;36(2):231-241. doi: 10.1038/onc.2016.194. Epub 2016 Jun 6.